Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2014-02-28
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild HAEMOPTYSIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-09 (study day 71.0); relationship: NONE
mild
assessed
Mild HAEMOPTYSIS — outcome: RECOVERED/RESOLVED; onset 2014-05-09 (study day 71.0); relationship: NONE
mild
assessed
Mild RALES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-05-23 (study day 85.0); relationship: NONE
mild
assessed
Mild RALES — outcome: RECOVERED/RESOLVED; onset 2014-05-23 (study day 85.0); relationship: NONE
Data queries
No data queries.